Patents by Inventor Uzair UR-REHMAN

Uzair UR-REHMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EGFR gene expression-suppressing siRNA, precursor of same, and applications thereof
    Patent number: 11304970
    Abstract: Provided are an EGFR gene expression-suppressing siRNA, a precursor sequence of same, and uses thereof.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: April 19, 2022
    Assignee: JIANGSU MICROMEDMARK BIOTECH CO., LTD.
    Inventors: Chenyu Zhang, Xi Chen, Hongwei Liang, Uzair Ur-Rehman
  • K-RAS gene expression-suppressing siRNA, precursor of same, and applications thereof
    Patent number: 10982213
    Abstract: The present invention discloses an siRNA that inhibits K-RAS gene expression, and the precursor sequences and applications thereof. The K-RAS siRNA and its precursor sequences provided by the present invention can efficiently inhibit the expression of the K-RAS gene, and in vivo experiments have shown that the K-RAS siRNA has a certain inhibitory effect on tumours highly expressing K-RAS. The precursor of the siRNA of the invention and its vector can form a stable siRNA that functions in a host.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: April 20, 2021
    Assignee: JIANGSU MICROMEDMARK BIOTECH CO., LTD.
    Inventors: Chenyu Zhang, Xi Chen, Hongwei Liang, Uzair Ur-Rehman, Ke Zeng
  • K-RAS GENE EXPRESSION-SUPPRESSING SIRNA, PRECURSOR OF SAME, AND APPLICATIONS THEREOF
    Publication number: 20190382769
    Abstract: The present invention discloses an siRNA that inhibits K-RAS gene expression, and the precursor sequences and applications thereof. The K-RAS siRNA and its precursor sequences provided by the present invention can efficiently inhibit the expression of the K-RAS gene, and in vivo experiments have shown that the K-RAS siRNA has a certain inhibitory effect on tumours highly expressing K-RAS. The precursor of the siRNA of the invention and its vector can form a stable siRNA that functions in a host.
    Type: Application
    Filed: May 5, 2017
    Publication date: December 19, 2019
    Applicant: JIANGSU MICROMEDMARK BIOTECH CO., LTD.
    Inventors: Chenyu ZHANG, Xi CHEN, Hongwei LIANG, Uzair UR-REHMAN, Ke ZENG
  • EGFR GENE EXPRESSION-SUPPRESSING SIRNA, PRECURSOR OF SAME, AND APPLICATIONS THEREOF
    Publication number: 20190255090
    Abstract: Provided are an EGFR gene expression-suppressing siRNA, a precursor sequence of same, and uses thereof.
    Type: Application
    Filed: May 5, 2017
    Publication date: August 22, 2019
    Applicant: JIANGSU MICROMEDMARK BIOTECH CO., LTD.
    Inventors: Chenyu ZHANG, Xi CHEN, Hongwei LIANG, Uzair UR-REHMAN